Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
出版年份 2021 全文链接
标题
Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 124, Issue 10, Pages 1637-1646
出版商
Springer Science and Business Media LLC
发表日期
2021-03-15
DOI
10.1038/s41416-021-01320-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Functional Analysis Of Young Patients With Desmoid-Type Fibromatosis: Initial Surveillance Does Not Jeopardize Long Term Quality Of Life
- (2020) G. Duhil de Bénazé et al. EJSO
- The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
- (2020) Ben Alman et al. EUROPEAN JOURNAL OF CANCER
- Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis – A systematic analysis of 204 cases
- (2020) Marcel Trautmann et al. Scientific Reports
- Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors
- (2020) Erjian Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours
- (2020) Sara M. Federico et al. EUROPEAN JOURNAL OF CANCER
- Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
- (2020) Aaron R Weiss et al. LANCET ONCOLOGY
- Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy—A Multicenter Study by the French Sarcoma Group
- (2020) Amandine Crombé et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
- (2019) Maud Toulmonde et al. LANCET ONCOLOGY
- Sorafenib population pharmacokinetics and skin toxicities in children and adolescents with refractory/relapsed leukemia or solid tumor malignancies
- (2019) Hiroto Inaba et al. CLINICAL CANCER RESEARCH
- Desmoid-type fibromatosis of the head and neck in children: A changing situation
- (2019) Antoine Paul et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Periosteal Reaction Possibly Induced by Pazopanib
- (2019) Takahiro Hosokawa et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Pazopanib for progressive desmoid tumours: children, persistant effects, and cost
- (2019) Yoshihiro Nishida et al. LANCET ONCOLOGY
- Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
- (2018) Meinolf Suttorp et al. LEUKEMIA
- Pazopanib therapy for desmoid tumors in adolescent and young adult patients
- (2018) Laura Agresta et al. PEDIATRIC BLOOD & CANCER
- Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
- (2018) Monika Sparber-Sauer et al. PEDIATRIC BLOOD & CANCER
- Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR
- (2018) Nicolas Macagno et al. Oncotarget
- Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients
- (2018) Meinolf Suttorp et al. PEDIATRIC BLOOD & CANCER
- Sorafenib for Advanced and Refractory Desmoid Tumors
- (2018) Mrinal M. Gounder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)
- (2017) Bernd Kasper et al. EUROPEAN JOURNAL OF CANCER
- Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
- (2017) Nicolas Penel et al. EUROPEAN JOURNAL OF CANCER
- Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib
- (2017) Christine M. Walko et al. ONCOLOGIST
- Pharmacology and pharmacokinetics of imatinib in pediatric patients
- (2017) Meinolf Suttorp et al. Expert Review of Clinical Pharmacology
- Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors
- (2016) Xiu-Feng Yin et al. Clinical Lymphoma Myeloma & Leukemia
- Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France
- (2016) Nicolas Penel et al. EUROPEAN JOURNAL OF CANCER
- Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy
- (2016) Rick Proschmann et al. HAEMATOLOGICA
- Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia
- (2016) Jill Samis et al. PEDIATRIC BLOOD & CANCER
- Adverse effects of imatinib in children with chronic myelogenous leukemia
- (2016) Worawut Choeyprasert et al. PEDIATRICS INTERNATIONAL
- Desmoid fibromatosis: MRI features of response to systemic therapy
- (2016) Pooja J. Sheth et al. SKELETAL RADIOLOGY
- Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy
- (2016) Rick Proschmann et al. HAEMATOLOGICA
- Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four cases
- (2016) Keiko Okada et al. Cancer Medicine
- AKT1andBRAFmutations in pediatric aggressive fibromatosis
- (2016) Cristina Meazza et al. Cancer Medicine
- Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival
- (2015) S. Salas et al. CLINICAL CANCER RESEARCH
- Near universal detection of alterations inCTNNB1and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis
- (2015) Aimee M. Crago et al. GENES CHROMOSOMES & CANCER
- Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
- (2015) AeRang Kim et al. PEDIATRIC BLOOD & CANCER
- Impact of Long-Term Exposure to the Tyrosine Kinase Inhibitor Imatinib on the Skeleton of Growing Rats
- (2015) Josephine T. Tauer et al. PLoS One
- A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis
- (2014) Jae-Cheol Jo et al. INVESTIGATIONAL NEW DRUGS
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
- (2014) M. A. Karajannis et al. NEURO-ONCOLOGY
- Is Wide Resection Obsolete for Desmoid Tumors in Children and Adolescents? Evaluation of Histological Margins, Immunohistochemical Markers, and Review of Literature
- (2014) Nora Woltsche et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence
- (2013) Chiara Colombo et al. CANCER
- The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification
- (2013) Christopher D M Fletcher HISTOPATHOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report
- (2013) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- TK Inhibitor Treatment Disrupts Growth Hormone Axis: Clinical Observations in Children with CML and Experimental Data from a Juvenile Animal Model
- (2013) A. Ulmer et al. KLINISCHE PADIATRIE
- Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment
- (2013) Bernadette Anna Sophia Jaeger et al. MEDICAL SCIENCE MONITOR
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Nouvelle classification de l’OMS des tumeurs des tissus mous et des os
- (2012) Jean-Michel Coindre ANNALES DE PATHOLOGIE
- Phase I and Clinical Pharmacology Study of Bevacizumab, Sorafenib, and Low-Dose Cyclophosphamide in Children and Young Adults with Refractory/Recurrent Solid Tumors
- (2012) F. Navid et al. CLINICAL CANCER RESEARCH
- A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report
- (2012) B. C. Widemann et al. CLINICAL CANCER RESEARCH
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
- (2012) AeRang Kim et al. PEDIATRIC BLOOD & CANCER
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- (2011) M. M. Gounder et al. CLINICAL CANCER RESEARCH
- Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression
- (2011) Hiroshi Matono et al. HISTOPATHOLOGY
- Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy
- (2010) Ryan C. Fields et al. ANNALS OF SURGICAL ONCOLOGY
- Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial
- (2010) R. Chugh et al. CLINICAL CANCER RESEARCH
- External-beam radiotherapy for pediatric and young adult desmoid tumors
- (2010) Michael S. Rutenberg et al. PEDIATRIC BLOOD & CANCER
- Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment
- (2009) Marco Fiore et al. ANNALS OF SURGICAL ONCOLOGY
- Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
- (2009) Anastasia Constantinidou et al. EUROPEAN JOURNAL OF CANCER
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started